Cargando…
Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial
BACKGROUND: Erythropoietin (EPO) has been suggested to promote cardiac repair after MI. However, the randomized, double-blind, placebo controlled REVIVAL-3 trial showed that short term high dose EPO in timely reperfused myocardium does not improve left ventricular ejection fraction after 6 months. M...
Autores principales: | Steppich, Birgit, Groha, Philip, Ibrahim, Tareq, Schunkert, Heribert, Laugwitz, Karl-Ludwig, Hadamitzky, Martin, Kastrati, Adnan, Ott, Ilka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5251242/ https://www.ncbi.nlm.nih.gov/pubmed/28109258 http://dx.doi.org/10.1186/s12872-016-0464-3 |
Ejemplares similares
-
ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
por: Ott, Ilka, et al.
Publicado: (2017) -
Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction
por: Steppich, Birgit A, et al.
Publicado: (2009) -
Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction
por: Sager, Hendrik B., et al.
Publicado: (2019) -
Association of In‐Hospital Hemoglobin Drop With Decreased Myocardial Salvage and Increased Long‐Term Mortality in Patients With Acute ST‐Segment–Elevation Myocardial Infarction
por: Dutsch, Alexander, et al.
Publicado: (2022) -
Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction
por: Stein, Andreas, et al.
Publicado: (2010)